Diagnose und kausale Therapie der Sepsis

Baddour LM, Yu VL, Klugman KP et al. (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170: 440–444

Barie P, Williams M, McCollam J et al. (2004) Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188: 212–222

Centers for Disease Control and Prevention http://www.cdc.gov/ncidod/hip/NNIS/members/2001NNIS_report.pdf

Chastre J, Wolff M, Fagon JY et al. (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 290: 2588–2598

Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 363: 600–607

ClinicalTrials.gov (2009) Comparison of two antibiotic regimen (meropenem versus meropenem+moxifloxacin) in the treatment of severe sepsis and septic shock (MaxSep). http://clinicaltrials.gov/ct2/show/study/NCT00534287?view=results

Engel C, Brunkhorst FM, Bone HG et al. (2007) Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 33: 606–618

European Antimicrobial Resistance Surveillance System (2008) EARSS Annual Report 2007. http://www.rivm.nl/earss/Images/EARSS%202007_FINAL_tcm61-55933.pdf

Harbarth S, Holeckova K, Froidevaux C et al. (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164: 396–402

Heyland D, Dodek P, Muscedere J, Day A; Canadian Critical Care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355: 2619–2630

Kujath P, Eckmann C, Esnaashari H, Bruch HP (2007) The value of different lavage treatment patterns in diffuse peritonitis. Zentralbl Chir 132: 427–432

Kumar A, Roberts D, Wood KE (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589–1596

Levy MM, Fink MP, Marshall JC et al. for the International Sepsis Definitions Conference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538

Mandell LA, Bartlett JG, Dowell SF et al. (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37(11): 1405–1433

Meisner M (2000) Procalcitonin. A new, innovative infection parameter, 3rd ed. Thieme, Stuttgart

Micek ST, Lloyd AE, Ritchie DJ et al. (2005) Pseudomonas aeruginosa bloodstream infection: Importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49: 1306–1311

Nobre V, Harbarth S, Graf JD et al. (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: A randomized trial. Am J Respir Crit Care Med 177: 498–505

Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ 328: 668

Rangel-Frausto MS, Pittet D, Costigan M et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117–123

Reimer LG, Wilson ML, Weinstein MP (1997) Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10: 444–465

Reinhart K, Brunkhorst FM, Bone HG et al. (2006) Diagnose und Therapie der Sepsis: S2-Leitlinien der Deutschen Sepsisgesellschaft e.V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI). Internist (Berl) 47: 356–373

Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4: 519–527

Schrenzel J (2007) Clinical relevance of new diagnostic methods for bloodstream infections. Int J Antimicrob Agents (Suppl 1): S2–S6

Trouillet JL, Chastre J, Vuagnat A et al. (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157: 531–539